Document:

exv10w7

Exhibit 10.7

PROMISSORY NOTE

			
	 	 	 
	 
	 	January 7, 2011
	$200,000
	 	Hopkinton, Massachusetts

     FOR VALUE RECEIVED, Alseres Pharmaceuticals, Inc.. (the “Maker”), promises to pay to Robert L
Gipson, or order, at the offices of Robert L. Gipson, c/o Ingalls & Snyder LLC, 61 Broadway, New
York, New York 10006 or at such other place as the holder of this Note may designate, the principal
sum of $200,000, together with interest on the unpaid principal balance of this Note from time to
time outstanding at the rate of 7% per year until paid in full. All principal and accrued interest
shall be due and payable on demand of the Holder.

Interest on this Note shall be computed on the basis of a year of 365 days for the actual number of
days elapsed. All payments by the Maker under this Note shall be in immediately available funds.

Every amount overdue under this Note shall bear interest from and after the date on which such
amount first became overdue at an annual rate which is two (2) percentage points above the rate per
year specified in the first paragraph of this Note. Such interest on overdue amounts under this
Note shall be payable on demand and shall accrue and be compounded monthly until the obligation of
the Maker with respect to the payment of such interest has been discharged (whether before or after
judgment).

In no event shall any interest charged, collected or reserved under this Note exceed the maximum
rate then permitted by applicable law and if any such payment is paid by the Maker, then such
excess sum shall be credited by the holder as a payment of principal.

All payments by the Maker under this Note shall be made without set-off or counterclaim and be free
and clear and without any deduction or withholding for any taxes or fees of any nature whatever,
unless the obligation to make such deduction or withholding is imposed by law. The Maker shall pay
and save the holder harmless from all liabilities with respect to or resulting from any delay or
omission to make any such deduction or withholding required by law.

Whenever any amount is paid under this Note, all or part of the amount paid may be applied to
principal, premium or interest in such order and manner as shall be determined by the holder in its
discretion.

No reference in this Note to any guaranty or other document shall impair the obligation of the
Maker, which is absolute and unconditional, to pay all amounts under this Note strictly in
accordance with the terms of this Note.

The Maker agrees to pay on demand all costs of collection, including reasonable attorneys’ fees,
incurred by the holder in enforcing the obligations of the Maker under this Note.

 

 

No delay or omission on the part of the holder in exercising any right under this Note shall
operate as a waiver of such right or of any other right of such holder, nor shall any delay,
omission or waiver on any one occasion be deemed a bar to or waiver of the same or any other right
on any future occasion. The Maker and every endorser or guarantor of this Note regardless of the
time, order or place of signing waives presentment, demand, protest and notices of every kind and
assents to any extension or postponement of the time of payment or any other indulgence, to any
substitution, exchange or release of collateral, and to the addition or release of any other party
or person primarily or secondarily liable.

This Note may be prepaid in whole or in part at any time or from time to time upon five days’ prior
written notice with the consent of the holder, with the giving of such consent to be in the sole
discretion of the holder. Any such prepayment shall be without penalty or premium.

None of the terms or provisions of this Note may be excluded, modified or amended except by a
written instrument duly executed on behalf of the holder expressly referring to this Note and
setting forth the provision so excluded, modified or amended.

All rights and obligations hereunder shall be governed by the laws of the Commonwealth of
Massachusetts and this Note is executed as an instrument under seal.

	 	 	 	 	 
	 	Alseres Pharmaceuticals, Inc.

 	 
	 	By:  	/s/Kenneth L. Rice Jr
 	 
	 	 	Title: EVP & CFOexv4w1

     

Exhibit 4.1

 

 

	COMMON SITOCK COMMON STOCK INCORPORATED UNDER THE LAWS OF THE STATE OF NORTH CAROLINA COMMON STOCK
SHARES OF COMMON STOCK, PAR VALUE $0.01 PER SHARE OF PARK STERLING CORPORATION The shares evidenced by tills CeiltHCaW am Imnsieiable on Itie books ol the Corpomtioii by the tiolcler herool in person or l)y a duly aiUhonzed. attorney or legal representative, upon siirrencler of this Ceililiualo piopcily encbfsed. The shwos evidenced by this Ceiiificate are qmsoawbtQ under Section 5342 of Hie North Carolina General Statutes. This CerlJic&le &r,cl lite gharf s .epi^ Suiiiiu lieretiy are subject
 to all the provisions ol the Adicles of IncoippiatiOn and Bylaws of’lhe Cofpoi;4ioh and nil ennnd-imnlr thereto (copies ol which are’(^n lile v/ilhlheTiknsI^.’/-gent).,This Cerliticate is not valid unless countetsigned by the Tmnmfer Agon! and registeteU by Ih; %oHtrEr.
The’Coir.nion Slijck evidenced hy this Ceitificato is non-withdrav/able capital, is not ol insurat)le typo, and Is not insured by tlie Or-posit InsurArce F(/rd or rhy other Fund of ttie Federal Deposit InsLiranco Coiporation,
IN WITNESS WHfiHIiOF, the Coiporation has caused this Certilicale to be executed by the facsimile signatures of its duly autlioiizcd ofliceis and has caused its facsimile seal to be affixed hereto.
Dated:exv10w22

Exhibit 10.22

SEVERANCE AND NONCOMPETITION AGREEMENT

     THIS SEVERANCE AND NONCOMPETITION AGREEMENT (this “Agreement”) is made by and between SPARTECH
CORPORATION, a Delaware corporation (together with its subsidiaries, the “Company”) and
                     (“Employee”) effective as of the         day of December, 2008.

     In consideration of the terms and conditions hereof, and for other good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, the Company and
Employee agree as follows:

     1. Severance.

     (a) If Employee’s employment with the Company is terminated by the Company for any reason
other than for Cause, or if Employee’s employment with the Company is terminated by the Company for
any reason other than for Cause within 24 months following a Change in Control, or if Employee
terminates his or her employment with the Company for Good Reason, Employee shall be entitled to
receive as a severance payment to be paid in equal installments over the twelve months following
Employee’s termination, and in accordance with the Company’s normal payroll practices, an aggregate
amount equal to: (i) twelve months’ base salary at the highest rate paid to Employee during the
three years prior to Employee’s termination, plus (ii) the average annual bonus awarded to Employee
for the three fiscal years ended prior to Employee’s termination (or for the period of Employee’s
employment by the Company if less than three years). In addition to the foregoing severance
payment, Employee shall be entitled to receive during the twelve months following Employee’s
termination continuing health insurance benefits at least equal to the benefits received by
Employee at the time of termination.

     (b) As used herein:

     “Cause” means, in each case in the reasonable discretion of the Company’s board of directors
(the “Board”): (i) Employee being charged with commission of a crime that constitutes a felony
(provided that if following Employee’s termination the charges are dropped or Employee is acquitted
then Employee shall be entitled to the severance payment); (ii) acts of Employee which constitute
willful fraud or dishonesty on the part of Employee in connection with his or her duties; (iii)
Employee willfully engaging in conduct materially injurious to the Company or gross misconduct,
including but not limited to the willful or grossly negligent failure or refusal of Employee to
comply with the lawful instruction of the Board or Employee’s supervisor, after a written demand
for compliance is delivered to Employee by the Board or Employee’s supervisor which specifically
identifies the manner in which the Board or Employee’s supervisor believes that Employee has
violated this provision; (iv) Employee’s failure, whether or not intentional, to fully comply with:
(a) the Company’s Code of Business Conduct and Ethics for Directors, Officers and Employees, (b)
the Company’s Code of Ethics for Chief Executive Officer and Senior Financial Officers; or (c) the
Company’s Statement of Policy Regarding Securities Trades by Company Personnel; or (v) Employee’s
failure to fully cooperate in good faith with any internal, governmental or regulatory
investigation involving or in any way related to the Company or its operations. Any act or failure
to act based upon authority given pursuant to a resolution duly adopted by the Board or based on
the advice of a senior officer or counsel for the Company shall be conclusively presumed to be
done, or omitted to be done, by Employee in good faith and in the best interests of the Company.

     “Change in Control” means the successful consummation of a transaction resulting in a change
in the ownership or effective control of the Company or ownership of a substantial portion of the
assets of the Company within the meaning of Section 409A(a)(2)(C)(v) of the Internal Revenue Code
of 1986, as amended, or any successor statute (“Code”).

     “Good Reason” means any of the following: (i) one or more reductions of Employee’s base salary
amounting to 10% or more from Employee’s highest previous base salary, provided that any reduction
which is generally consistent with across-the-board reductions in pay of the Company as a whole
shall not be counted for this purpose unless a Change in Control has occurred; (ii) the Company’s
requiring Employee to be based at any office or location greater than 50 miles from the office of
the Company at which Employee is employed as of the date of this Agreement; (iii) after a Change in
Control, a relocation of the office of the Company at which Employee is employed as of the date of
this Agreement more than 50 miles from its present location; or (iv) one or more other actions by
the Company which collectively amount to a constructive discharge of Employee.

     (c) If Employee is a “specified employee” (within the meaning of Code Section
409A(a)(2)(B)(i)) of the Company at the time of his or her termination of employment with the
Company and if the separation payments under Section (a) are on account of his or her “involuntary
separation from service” (as defined in Treasury Regulation Section 1.409A-1(n), or a successor
regulation), Employee shall receive payments during the six (6) month period immediately following
the date of such termination as otherwise provided under Section (a) for such six month period
except that the total amount of such payments shall not exceed the lesser of the amount specified
under (i) Treasury Regulation Section 1.409A-1(b)(9)(iii)(A)(1) or (ii) Treasury Regulation Section
1.409A-1(b)(9)(iii)(A)(2) or successor regulations. To the extent the amounts otherwise payable
during such six (6) month period under Section (a) exceed the amounts payable under the immediately
preceding sentence,

 

 

such excess amounts, together with interest on such amounts from the date of Employee’s
termination of employment with the Company to the date of payment, shall be paid in a single sum on
the first regular payroll date of the Company immediately following the six (6) month anniversary
of the date of such termination. If the Company reasonably determines that such termination is not
an “involuntary separation from service” (as defined in Treasury Regulation Section 1.409A-1(n), or
a successor regulation), amounts otherwise payable during such six (6) month period immediately
following the date of Employee’s termination under Section (a), together with interest on such
amounts from the date of Employee’s termination of employment with the Company to the date of
payment, shall be paid in a single sum on the first payroll date of the Company immediately
following the six (6) month anniversary of such termination. For purposes of this Section (c),
“interest” means the prime rate, as announced from time to time by the Company’s primary commercial
bank during the six month period described above, plus two percentage points, compounded annually.

     2. Nondisclosure. During the period of Employee’s employment with the Company, and
after the termination thereof for any reason, Employee agrees to use his or her best efforts to
maintain and protect the secrecy of the Confidential Information and not to directly or indirectly
undertake or attempt to undertake: (i) any disclosure of any Confidential Information to any other
person or entity; (ii) to use any Confidential Information for Employee’s own purposes; (iii) to
make any copies or reproductions of any Confidential Information; (iv) to authorize or permit any
other person or entity to use, copy, disclose, publish or distribute any Confidential Information;
or (v) any activity the Company is prohibited from undertaking or attempting to undertake by any of
its present or future clients, customers, suppliers, vendors, consultants, agents or contractors.
As used herein, “Confidential Information” means any knowledge, information or property relating
to, or used or possessed by, the Company, and includes, without limitation, the following: trade
secrets; manufacturing or production know-how, methods and processes, patents, copyrights, software
(including, without limitation, all programs, specifications, applications, routines, subroutines,
techniques and ideas for formulas); concepts, data, drawings, designs and documents; names of
clients, customers, employees, agents, contractors, and suppliers; marketing information; financial
information and other business records; and all copies of any of the foregoing, including notes,
extracts, memoranda prepared or directed to be prepared by Employee based on any Confidential
Information. Employee agrees that all information possessed by Employee, or disclosed to Employee,
or to which Employee obtains access during the course of Employee’s employment with the Company
shall be presumed to be Confidential Information under the terms of this Agreement. Confidential
Information shall not include any information which is publicly available or which is generally
known to persons employed in the plastics processing business. Upon termination of Employee’s
employment with the Company for any reason, Employee agrees not to retain or remove from the
Company’s premises any Confidential Information whatsoever, and to surrender the same to the
Company, wherever it is located, immediately upon termination of Employee’s employment.

     3. Noncompetition/Nonsolicitation. Employee agrees that, during the term of
Employee’s employment with the Company and for a period of one (1) year after the termination of
Employee’s employment with the Company (whether such termination is with or without Cause or Good
Reason or results from Employee’s resignation) Employee shall not, directly or indirectly, in any
market in which the Company then is engaged in business activities (the “Geographic Area”): (i)
engage in, consult with, be employed by or be connected with any business or activity which
directly or indirectly competes with the Company’s business (a “Competing Business”), (ii) canvass,
solicit or accept any business from any of the Company’s current or former clients, (iii) own any
interest in any Competing Business (provided, however, Employee may own up to 1% of the outstanding
equity interests of any publicly traded Competing Business); (iv) assist others to open or operate
any Competing Business; (v) solicit, recommend or induce any employee of the Company to terminate
his or her employment with the Company; or (vi) solicit, recommend or induce any customers,
suppliers or any other person or entity which has a business relationship with the Company to
discontinue, reduce or modify such relationship.. Employee agrees and acknowledges that the
Geographic Area is reasonable in scope and that the one (1) year period is reasonable in length.
Employee has agreed to the foregoing noncompetition agreement because: (a) Employee recognizes that
the Company has a legitimate interest in protecting the confidentiality of its business secrets
(including the Confidential Information), (b) Employee agrees that such noncompetition agreement is
not oppressive to Employee nor injurious to the public, and (c) the Company has provided
specialized and valuable training and information to Employee.

     4. Injunction. Because the award of monetary damages would be an inadequate remedy,
in the event of a breach or threatened breach by Employee of any of the provisions of this
Agreement, the Company shall be entitled to an injunction restraining Employee from undertaking any
such breach or threatened breach. Nothing herein shall be construed as prohibiting the Company
from pursuing any other remedies for such breach or threatened breach, including the recovery of
damages from Employee.

     5. Amendment. No amendment, whether express or implied, to this Agreement shall be
effective unless it is in writing and signed by both parties hereto.

 

 

     6. Waiver. No consent or waiver, express or implied, by the Company to or of any
breach or default by Employee in the performance of his or her agreements hereunder shall operate
as a consent to or waiver of any other breach or default in the performance of the same or any
other obligations of Employee hereunder. The Company’s failure to complain of any such breach or
default shall not constitute a waiver by the Company of its rights hereunder, irrespective of how
long such failure continues.

     7. Governing Law; Venue. This Agreement shall be governed by, and construed under,
the laws of the State of Delaware. Each of the parties submits to the jurisdiction of the state
court sitting in St. Louis County, Missouri or federal court sitting in St. Louis, Missouri, in any
action or proceeding arising out of or relating to this Agreement and agrees that all such claims
may be heard and determined in any such court.

     8. Severability. The invalidity or unenforceability of any provision hereof shall in
no way affect the validity or enforceability of any other provision. In addition, should any time
or area restriction contained herein be found by a court to be unreasonable, such restriction shall
nevertheless remain as to the time or area such court finds reasonable, and as so amended, shall be
enforced.

     9. Miscellaneous. This Agreement shall apply to all periods when Employee is employed
by the Company irrespective of whether or not this Agreement is re-executed at the beginning of
each such period. This Agreement is binding upon and shall inure to the benefit of the parties’
heirs, representatives, affiliates, successors or assigns. The use of any gender shall include all
other genders. This Agreement replaces and supersedes the Severance and Noncompetition Agreement
between the parties.

	 	 	 	 	 	 	 	 	 	 	 

	SPARTECH CORPORATION	 	 	 	EMPLOYEE	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	By:

	 	 	 	 	 	By:	 	 	 	 
	 

	 	 
	 	 	 	 	 	 	 	 
	 

	 	President and Chief Executive Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00183-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00183-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00183-of-00352.parquet"}]]